AEPGX
Price
$65.36
Change
+$0.75 (+1.16%)
Updated
Aug 21 closing price
Net Assets
137.41B
FCIRX
Price
$19.02
Change
+$0.10 (+0.53%)
Updated
Aug 21 closing price
Net Assets
475.34M
Interact to see
Advertisement

AEPGX vs FCIRX

AEPGX vs FCIRX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. FCIRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a StrongBuy and FCIRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 137B vs. FCIRX (475M). AEPGX pays higher dividends than FCIRX: AEPGX (2.56) vs FCIRX (0.52). AEPGX was incepted earlier than FCIRX: AEPGX (42 years) vs FCIRX (9 years). FCIRX (1.25) is less costly to investors than AEPGX (0.83). AEPGX is a more actively managed with annual turnover of: 50.00 vs. FCIRX (25.00). AEPGX (6%) and FCIRX (6%) have equivalent initial investment costs. AEPGX has a lower initial minimum investment than FCIRX: AEPGX (250) vs FCIRX (15000). FCIRX annual gain was more profitable for investors over the last year : 11.71 vs. AEPGX (8.66). FCIRX return over 5 years is better than : 22.63 vs. AEPGX (1.00).
AEPGXFCIRXAEPGX / FCIRX
Total Expense Ratio0.831.2069%
Annual Report Gross Expense Ratio0.831.2566%
Fund Existence42 years9 years-
Gain YTD8.0156.674120%
Front Load6%6%105%
Min. Initial Investment250150002%
Min. Initial Investment IRAN/AN/A-
Net Assets137B475M28,842%
Annual Yield % from dividends2.560.52496%
Returns for 1 year8.6611.7174%
Returns for 3 years30.3032.1594%
Returns for 5 years1.0022.634%
Returns for 10 years47.95N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOLT3.690.52
+16.40%
Bolt Biotherapeutics Inc
RENT3.800.14
+3.83%
Rent the Runway
POST80.501.98
+2.52%
Post Holdings
WASH39.710.34
+0.86%
Washington Trust Bancorp
ROIV36.30-0.54
-1.47%
Roivant Sciences Ltd